Severe neurodevelopmental disease caused by a homozygous TLK2 variant

被引：0
|
作者：
Topf, A. [1 ]
Oktay, Y. [2 ]
Balaraju, S. [1 ]
Yilmaz, E. [2 ]
Sonmezler, E. [2 ]
Yis, U. [3 ]
Laurie, S. [4 ]
Thompson, R. [1 ]
Roos, A. [1 ,5 ]
MacArthur, D. G. [6 ,7 ]
Yaramis, A. [8 ]
Gungor, S. [9 ]
Lochmueller, H. [4 ,10 ,11 ,12 ]
Hiz, S. [3 ]
Horvath, R. [13 ]
机构：
[1] Newcastle Univ, Inst Med Genet, John Walton Muscular Dystrophy Res Ctr, Newcastle, England
[2] Dokuz Eylul Univ, Izmir Biomed & Genome Ctr, Hlth Campus, Izmir, Turkey
[3] Dokuz Eylul Univ, Sch Med, Dept Paediat Neurol, Izmir, Turkey
[4] Barcelona Inst Sci & Technol, Ctr Genom Regulat, CRG, CNAG, Barcelona, Spain
[5] Leibniz Inst Analyt Wissensch, ISAS, Dortmund, Germany
[6] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA
[7] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA
[8] Diyarbakir Mem Hosp, Pediat Neurol Clin, Diyarbakir, Turkey
[9] Inonu Univ, Dept Paediat Neurol, Turgut Ozal Res Ctr, Fac Med, Malatya, Turkey
[10] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada
[11] Ottawa Hosp, Div Neurol, Dept Med, Ottawa, ON, Canada
[12] Univ Freiburg, Med Ctr, Fac Med, Dept Neuropediat & Muscle Disorders, Freiburg, Germany
[13] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2019年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
E-P08.19
引用
收藏
页码：1850 / 1851
页数：2
相关论文
共 50 条
  • [1] Severe neurodevelopmental disease caused by a homozygous TLK2 variant
    Topf, Ana
    Oktay, Yavuz
    Balaraju, Sunitha
    Yilmaz, Elmasnur
    Sonmezler, Ece
    Yis, Uluc
    Laurie, Steven
    Thompson, Rachel
    Roos, Andreas
    MacArthur, Daniel G.
    Yaramis, Ahmet
    Gungor, Serdal
    Lochmueller, Hanns
    Hiz, Semra
    Horvath, Rita
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (03) : 383 - 387
  • [2] Severe neurodevelopmental disease caused by a homozygous TLK2 variant
    Ana Töpf
    Yavuz Oktay
    Sunitha Balaraju
    Elmasnur Yilmaz
    Ece Sonmezler
    Uluc Yis
    Steven Laurie
    Rachel Thompson
    Andreas Roos
    Daniel G. MacArthur
    Ahmet Yaramis
    Serdal Güngör
    Hanns Lochmüller
    Semra Hiz
    Rita Horvath
    European Journal of Human Genetics, 2020, 28 : 383 - 387
  • [3] Neurodevelopmental disorder caused by homozygous variant in NTNG2
    Safran, Amit
    Proskorovski-Ohayon, Regina
    Birk, Ohad Shmuel
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 199 - 200
  • [4] Case report: A novel TLK2 variant with a neuropsychiatric phenotype from a Chinese family
    Huang, Hongmei
    Qian, Yue
    Yang, Chenlu
    Li, Shijie
    FRONTIERS IN GENETICS, 2024, 15
  • [5] TLK2: a target for cancer and viral latency
    Pozzetti, Luca
    East, Michael P.
    Laitinen, Tuomo
    Asquith, Christopher R. M.
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (12) : 886 - 886
  • [6] Report of two children with global developmental delay in association with de novo TLK2 variant and literature review
    Woods, Emily
    Spiller, Michael
    Balasubramanian, Meena
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2022, 188 (03) : 931 - 940
  • [7] The potential role of TLK2 as a therapeutic target in breast cancer.
    Kim, J-A
    Cao, X.
    Tan, Y.
    Schiff, R.
    Wang, X.
    CANCER RESEARCH, 2012, 72
  • [8] De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder
    Reijnders, Margot R. F.
    Miller, Kerry A.
    Alvi, Mohsan
    Goos, Jacqueline A. C.
    Lees, Melissa M.
    de Burca, Anna
    Henderson, Alex
    Kraus, Alison
    Mikat, Barbara
    de Vries, Bert B. A.
    Isidor, Bertrand
    Kerr, Bronwyn
    Marcelis, Carlo
    Schluth-Bolard, Caroline
    Deshpande, Charu
    Ruivenkamp, Claudia A. L.
    Wieczorek, Dagmar
    Baralle, Diana
    Blair, Edward M.
    Engels, Hartmut
    Luedecke, Hermann-Josef
    Eason, Jacqueline
    Santen, Gijs W. E.
    Clayton-Smith, Jill
    Chandler, Kate
    Tatton-Brown, Katrina
    Payne, Katelyn
    Helbig, Katherine
    Radtke, Kelly
    Nugent, Kimberly M.
    Cremer, Kirsten
    Strom, Tim M.
    Bird, Lynne M.
    Sinnema, Margje
    Bitner-Glindzicz, Maria
    van Dooren, Marieke F.
    Alders, Marielle
    Koopmans, Marije
    Brick, Lauren
    Kozenko, Mariya
    Harline, Megan L.
    Klaassens, Merel
    Steinraths, Michelle
    Cooper, Nicola S.
    Edery, Patrick
    Yap, Patrick
    Terhal, Paulien A.
    van der Spek, Peter J.
    Lakeman, Phillis
    Taylor, Rachel L.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2018, 102 (06) : 1195 - 1203
  • [9] Report of one case with de novo mutation in TLK2 and literature review
    Li, Han-Yue
    Jiang, Chun-Ming
    Liu, Ruo-Yan
    Zou, Chao-Chun
    BMC PEDIATRICS, 2024, 24 (01)
  • [10] TLK2 promotes progression of hepatocellular carcinoma through Wnt/β-catenin signaling
    He, Ting
    Xu, Borui
    Ma, Haiqing
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07)
12345